Our dermatology study experience spans from consulting on pre-investigational new drug (IND) briefing packages to preparing multiphase product development plans and from assembling new drug applications (NDAs) to providing biostatistical analyses.
We conducted or supported 51 protocols in dermatologic indications involving more than 4,500 patients and 730 sites between January 2004 and July 2009.
We are experienced in clinical monitoring, clinical project management and market research, and have been involved in various types of trials from small Phase I studies involving healthy volunteers to large, global, multicenter Phase III trials.
PPD has dermatology clinical research experience in a variety of areas including: